CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy
- Submitting institution
-
University of Bristol
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 197254327
- Type
- D - Journal article
- DOI
-
10.1093/eurheartj/ehy249
- Title of journal
- European Heart Journal
- Article number
- -
- First page
- 3879
- Volume
- 39
- Issue
- 43
- ISSN
- 0195-668X
- Open access status
- Compliant
- Month of publication
- May
- Year of publication
- 2018
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
16
- Research group(s)
-
A - Cardiovascular Science
- Citation count
- 57
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- a. The author made a substantial contribution to carrying out the study and to analysis and interpretation of study data.
b. The author critiqued the output for important intellectual content.
- Non-English
- No
- English abstract
- -
